Quantitative Large-Scale Three-Dimensional Imaging of Human Kidney Biopsies: A Bridge to Precision Medicine in Kidney Disease

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Kidney biopsy remains the gold standard for uncovering the pathogenesis of acute and chronic kidney diseases. However, the ability to perform high resolution, quantitative, molecular and cellular interrogation of this precious tissue is still at a developing stage compared to other fields such as oncology. Here, we discuss recent advances in performing large-scale, three-dimensional (3D), multi-fluorescence imaging of kidney biopsies and quantitative analysis referred to as 3D tissue cytometry. This approach allows the accurate measurement of specific cell types and their spatial distribution in a thick section spanning the entire length of the biopsy. By uncovering specific disease signatures, including rare occurrences, and linking them to the biology in situ, this approach will enhance our understanding of disease pathogenesis. Furthermore, by providing accurate quantitation of cellular events, 3D cytometry may improve the accuracy of prognosticating the clinical course and response to therapy. Therefore, large-scale 3D imaging and cytometry of kidney biopsy is poised to become a bridge towards personalized medicine for patients with kidney disease.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalNephron
DOIs
StateAccepted/In press - Jun 5 2018

Fingerprint

Precision Medicine
Three-Dimensional Imaging
Kidney Diseases
Kidney
Biopsy
Optical Imaging
Chronic Renal Insufficiency
Therapeutics

Keywords

  • Kidney biopsy
  • Three-dimensional imaging
  • Tissue cytometry

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Urology
  • Physiology (medical)

Cite this

@article{fd03421b12fe45559d8b69e3135fc633,
title = "Quantitative Large-Scale Three-Dimensional Imaging of Human Kidney Biopsies: A Bridge to Precision Medicine in Kidney Disease",
abstract = "Kidney biopsy remains the gold standard for uncovering the pathogenesis of acute and chronic kidney diseases. However, the ability to perform high resolution, quantitative, molecular and cellular interrogation of this precious tissue is still at a developing stage compared to other fields such as oncology. Here, we discuss recent advances in performing large-scale, three-dimensional (3D), multi-fluorescence imaging of kidney biopsies and quantitative analysis referred to as 3D tissue cytometry. This approach allows the accurate measurement of specific cell types and their spatial distribution in a thick section spanning the entire length of the biopsy. By uncovering specific disease signatures, including rare occurrences, and linking them to the biology in situ, this approach will enhance our understanding of disease pathogenesis. Furthermore, by providing accurate quantitation of cellular events, 3D cytometry may improve the accuracy of prognosticating the clinical course and response to therapy. Therefore, large-scale 3D imaging and cytometry of kidney biopsy is poised to become a bridge towards personalized medicine for patients with kidney disease.",
keywords = "Kidney biopsy, Three-dimensional imaging, Tissue cytometry",
author = "Seth Winfree and Pierre Dagher and Kenneth Dunn and Michael Eadon and Michael Ferkowicz and Daria Barwinska and Katherine Kelly and Timothy Sutton and {Ashkar (El-Achkar)}, Tarek",
year = "2018",
month = "6",
day = "5",
doi = "10.1159/000490006",
language = "English (US)",
pages = "1--6",
journal = "Nephron - Experimental Nephrology",
issn = "1660-8151",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Quantitative Large-Scale Three-Dimensional Imaging of Human Kidney Biopsies

T2 - A Bridge to Precision Medicine in Kidney Disease

AU - Winfree, Seth

AU - Dagher, Pierre

AU - Dunn, Kenneth

AU - Eadon, Michael

AU - Ferkowicz, Michael

AU - Barwinska, Daria

AU - Kelly, Katherine

AU - Sutton, Timothy

AU - Ashkar (El-Achkar), Tarek

PY - 2018/6/5

Y1 - 2018/6/5

N2 - Kidney biopsy remains the gold standard for uncovering the pathogenesis of acute and chronic kidney diseases. However, the ability to perform high resolution, quantitative, molecular and cellular interrogation of this precious tissue is still at a developing stage compared to other fields such as oncology. Here, we discuss recent advances in performing large-scale, three-dimensional (3D), multi-fluorescence imaging of kidney biopsies and quantitative analysis referred to as 3D tissue cytometry. This approach allows the accurate measurement of specific cell types and their spatial distribution in a thick section spanning the entire length of the biopsy. By uncovering specific disease signatures, including rare occurrences, and linking them to the biology in situ, this approach will enhance our understanding of disease pathogenesis. Furthermore, by providing accurate quantitation of cellular events, 3D cytometry may improve the accuracy of prognosticating the clinical course and response to therapy. Therefore, large-scale 3D imaging and cytometry of kidney biopsy is poised to become a bridge towards personalized medicine for patients with kidney disease.

AB - Kidney biopsy remains the gold standard for uncovering the pathogenesis of acute and chronic kidney diseases. However, the ability to perform high resolution, quantitative, molecular and cellular interrogation of this precious tissue is still at a developing stage compared to other fields such as oncology. Here, we discuss recent advances in performing large-scale, three-dimensional (3D), multi-fluorescence imaging of kidney biopsies and quantitative analysis referred to as 3D tissue cytometry. This approach allows the accurate measurement of specific cell types and their spatial distribution in a thick section spanning the entire length of the biopsy. By uncovering specific disease signatures, including rare occurrences, and linking them to the biology in situ, this approach will enhance our understanding of disease pathogenesis. Furthermore, by providing accurate quantitation of cellular events, 3D cytometry may improve the accuracy of prognosticating the clinical course and response to therapy. Therefore, large-scale 3D imaging and cytometry of kidney biopsy is poised to become a bridge towards personalized medicine for patients with kidney disease.

KW - Kidney biopsy

KW - Three-dimensional imaging

KW - Tissue cytometry

UR - http://www.scopus.com/inward/record.url?scp=85048159593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048159593&partnerID=8YFLogxK

U2 - 10.1159/000490006

DO - 10.1159/000490006

M3 - Article

C2 - 29870980

AN - SCOPUS:85048159593

SP - 1

EP - 6

JO - Nephron - Experimental Nephrology

JF - Nephron - Experimental Nephrology

SN - 1660-8151

ER -